Ats statement

Did you know most people with
NTM also have Bronchiectasis?

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

The ATS/IDSA Statement outlines recommended NTM treatment guidelines for various species. Though these recommendations are based on all available knowledge and expertise, every patient is different, and so your doctor may decide to change your regimen based on how you respond to treatment. These treatment variations are also discussed in some detail in the Statement.

Read the Statement

Charles L. Daley, Jonathan M. Iaccarino Jr., Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, Claire Andrejak, Erik C. Böttger, Jan Brozek, David E. Griffith, Lorenzo Guglielmetti, Gwen A. Huitt, Shandra L. Knight, Philip Leitman, Theodore K. Marras, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner, and Kevin L. Winthrop.